Compare

Omada Health, Inc. vs GeneDx Holdings Corp. vs U S Physical Therapy Inc vs InnovAge Holding Corp.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearOmada Health, Inc.
OMDA
GeneDx Holdings Corp.
WGS
U S Physical Therapy Inc
USPH
InnovAge Holding Corp.
INNV
Year ended2025-12-312025-12-312025-12-312026-06-30
Revenue$260.21M$427.54M$780.99M$989.71M
Revenue growth (YoY)+53.2%+40.0%+16.3%+15.9%
Gross margin65.7%69.7%19.2%23.0%
Operating margin-4.6%-3.1%11.1%0.3%
Net margin-4.9%-4.9%5.1%-0.3%
Net income-$12.78M-$21.02M$39.58M-$2.54M
EPS (Diluted)-$0.35-$0.73$1.42-$0.02
Operating cash flow$18.25M$33.28M$75.06M$64.71M
Free cash flow$16.93M$14.26M$60.99M$50.41M
Cash & equivalents$222.04M$105.00M$35.57M$97.89M
Total assets$305.41M$523.71M$1.20B$557.39M
Total liabilities$75.73M$215.53M$433.81M$288.62M
Shareholders' equity$229.68M$308.18M$476.89M$235.60M
Return on year-end equity-5.6%-6.8%8.3%-1.1%
Shares outstanding58.43M29.25Mn/a136.02M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearOmada Health, Inc.GeneDx Holdings Corp.U S Physical Therapy IncInnovAge Holding Corp.
Latest$260.21M
Ended 2025-12-31
$427.54M
Ended 2025-12-31
$780.99M
Ended 2025-12-31
$989.71M
Ended 2026-06-30
1 year earlier$169.80M
Ended 2024-12-31
$305.45M
Ended 2024-12-31
$671.35M
Ended 2024-12-31
$853.70M
Ended 2025-06-30
2 years earlier$122.78M
Ended 2023-12-31
$202.57M
Ended 2023-12-31
$604.80M
Ended 2023-12-31
$763.86M
Ended 2024-06-30
3 years earliern/a$234.69M
Ended 2022-12-31
$553.14M
Ended 2022-12-31
$688.09M
Ended 2023-06-30
4 years earliern/a$212.19M
Ended 2021-12-31
$495.02M
Ended 2021-12-31
$698.64M
Ended 2022-06-30